PATENT CLAIM ANALYSIS

Application Number: 15916371
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "769000"]

Abstract:
A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.

Claim (Index 10):
The A composition according to  claim 1 , wherein the cyclodextrin or derivative thereof is selected from the group consisting of \u03b1-cyclodextrin; \u03b2-cyclodextrin, \u03b3-cyclodextrin; hydroxypropyl-cyclodextrin, sulfobutylether \u03b2-cyclodextrin, dodecakis-2,6,O-methyl-\u03b1-cyclodextrin, tetradecakis-2,6,O-methyl-\u03b2-cyclodextrin, hexadecakis-2,6,O-methyl-\u03b3-cyclodextrin, tetradecakis-2,6,O-ethyl-\u03b2-cyclodextrin, \u03b1-cyclodextrin partially etherized with 2-hydroxypropyl, \u03b2-cyclodextrin partially etherized with 2-hydroxypropyl, branched \u03b1-cyclodextrin, and branched \u03b2-cyclodextrin where glucose or maltose has been bound via \u03b1-1,6 glucoside bound.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14009241', '12189323', '14842517', '11198710', '14435346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7448648139757864
- 35 USC 102 Novelty (BERT): 0.5313631064124503
- Combined Prediction Score: 0.7235146432194528
- Mean Citation Score: 191.739828
- Max Citation Score: 344.9039
- Similarity Product: 306.2597421302676

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test